Asia · Agencias y tiempo real · Focus Taiwan (CNA)

PharmaEssentia seeks to expand access to blood cancer drug in Europe

Publicado por Focus Taiwan (CNA) · Taiwán hace 12 h

Taiwan-based drugmaker PharmaEssentia Corp. is seeking to expand patient access to its blood cancer drug Ropeg in Europe, where the treatment has yet to receive regulatory…

Leer el artículo completo en Focus Taiwan (CNA) Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (focustaiwan.tw)

PharmaEssentia seeks to expand access to blood cancer drug in Europe

También te puede interesar

Indonesia, WHO bolster herbal medicine control to tap economic benefit

Meeting higher standards helps enhance competitiveness of Vietnam’s handicrafts

Bangladesh deploys additional paramilitary forces as garment workers’ protests continue

9-year-old student dies after collapsing in classroom; police examine CCTV footage, investigation underway

Over 7K Cordillera beneficiaries receive land titles from DAR

European firms find business certainty, reliability at south China's Canton Fair

PharmaEssentia seeks to expand access to blood cancer drug in Europe

Compartir

También te puede interesar

Indonesia, WHO bolster herbal medicine control to tap economic benefit

Meeting higher standards helps enhance competitiveness of Vietnam’s handicrafts

Bangladesh deploys additional paramilitary forces as garment workers’ protests continue

9-year-old student dies after collapsing in classroom; police examine CCTV footage, investigation underway

Over 7K Cordillera beneficiaries receive land titles from DAR

European firms find business certainty, reliability at south China's Canton Fair